Stockscreener 앱 받기
0.5414
0.59%
-0.0032
시간 외 거래:
.55
0.0086
+1.59%
Xilio Therapeutics Inc 주식(XLO)의 최신 뉴스
XLO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Press Release: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference - The Manila Times
Xilio Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
XLO PE Ratio & Valuation, Is XLO Overvalued - Intellectia AI
Is Xilio Therapeutics Inc. benefiting from innovation trendsPortfolio Performance Report & Free Technical Confirmation Trade Alerts - mfd.ru
Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split - The Globe and Mail
Xilio Therapeutics (NASDAQ: XLO) gains stockholder OK for reverse stock split range - Stock Titan
Entry Recap: Why is Xilio Therapeutics Inc stock going down2025 Top Gainers & Capital Efficient Trading Techniques - baoquankhu1.vn
Will Xilio Therapeutics Inc. stock reach Wall Street targetsWeekly Investment Report & Fast Gaining Stock Strategy Reports - mfd.ru
Bain Capital Life Sciences reports 9.99% Xilio (XLO) stake capped by blocker - Stock Titan
What is the long term forecast for Xilio Therapeutics Inc. stockEarnings Overview Report & High Yield Equity Trading Tips - mfd.ru
Frazier Life Sciences funds detail Xilio Therapeutics (XLO) ownership and warrants - Stock Titan
What is the Moat Score of Xilio Therapeutics Inc.July 2025 Opening Moves & Daily Volume Surge Trade Alerts - mfd.ru
Xilio Therapeutics Prices Pre-Funded Warrant Offering Financing - TipRanks
Xilio Therapeutics Signs Underwriting Agreement With Leerink Partners - TradingView
Xilio Therapeutics (NASDAQ: XLO) raises ~$40M via 74.8M pre-funded warrants - Stock Titan
Gilead discloses 19.9% stake in Xilio Therapeutics (XLO) ownership filing - Stock Titan
Xilio Therapeutics Launches Pre-Funded Warrant Offering - Intellectia AI
Xilio Therapeutics Prices $40M Underwritten Offering - National Today
Xilio Therapeutics Prices Pre-Funded Warrant Offering - Intellectia AI
Xilio Therapeutics Announces Pricing of Underwritten Offering - Yahoo Finance
Xilio Therapeutics announces pricing of underwritten offering - marketscreener.com
Xilio Therapeutics Announces Pricing Of Underwritten Offering - TradingView
Xilio Therapeutics Announces Pricing of $40 Million Underwritten Offering of Pre-Funded Warrants - Quiver Quantitative
Cancer drug developer Xilio raises $40M in warrant deal - Stock Titan
Can Xilio Therapeutics Inc. expand into new marketsDollar Strength & Entry Point Confirmation Signals - mfd.ru
Xilio (XLO) cuts Leerink-led stock offering capacity to $9.5M - Stock Titan
Xilio Therapeutics (NASDAQ:XLO) Shares Up 0.9% – Still a Buy? - Defense World
Earnings Risk: Can Xilio Therapeutics Inc deliver alphaM&A Rumor & Verified Short-Term Trading Plans - baoquankhu1.vn
Aug PostEarnings: Can Xilio Therapeutics Inc deliver alphaWeekly Investment Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Growth Recap: How cyclical is Xilio Therapeutics Incs revenue streamCPI Data & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Sell Signal: What is AAMUs market position2025 Dividend Review & High Win Rate Trade Tips - baoquankhu1.vn
Highs Report: What is Espey Mfg Electronics Corps market positionJuly 2025 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn
US Stocks Recap: Whats the fair value of Xilio Therapeutics Inc stockShort Setup & Technical Pattern Alert System - baoquankhu1.vn
Growth Recap: What is the long term forecast for Xilio Therapeutics Inc stock2025 Volatility Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Xilio Therapeutics (NASDAQ: XLO) reverse split vote to keep listing - Stock Titan
Performance Recap: Is Xilio Therapeutics Inc in accumulation or distribution phase2025 Biggest Moves & High Win Rate Trade Alerts - baoquankhu1.vn
Update Recap: Can Xilio Therapeutics Inc sustain earnings growthJuly 2025 Final Week & Weekly Hot Stock Watchlists - baoquankhu1.vn
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates - Sahm
What dividend safety score for Xilio Therapeutics Inc. stockPortfolio Update Report & Technical Pattern Based Signals - Улправда
How Xilio Therapeutics Inc. stock reacts to bond yieldsWeekly Investment Summary & Weekly High Return Forecasts - Улправда
Is Xilio Therapeutics Inc. stock a contrarian buyEarnings Summary Report & Weekly Sector Rotation Insights - Улправда
Xilio Therapeutics secures $35.8 million from warrant exercises By Investing.com - Investing.com India
Xilio Therapeutics, Inc. Announces Change of Chair of the Board of Directors - MarketScreener
Why Xilio Therapeutics Inc. stock attracts high net worth investorsWeekly Trend Summary & Breakout Confirmation Alerts - ulpravda.ru
Xilio Therapeutics extends cash runway into 2027 - MSN
Xilio Therapeutics Inc appoints Sara Bonstein as chair of board - MarketScreener
Xilio Therapeutics Announces Leadership Transition and Pipeline Updates - TipRanks
Xilio Therapeutics Announces Board Leadership Change - TradingView — Track All Markets
Is Xilio Therapeutics Inc. stock supported by strong fundamentalsMarket Risk Analysis & Safe Entry Point Alerts - Улправда
Xilio Therapeutics secures $35.8 million from warrant exercises - Investing.com
Xilio Therapeutics (NASDAQ: XLO) updates cash and appoints new board chair - Stock Titan
Biotech Xilio brings in $35.8M to advance masked cancer therapies - Stock Titan
Xilio Therapeutics Extends Cash Runway Into 2027 - The Globe and Mail
Xilio shares soar on AbbVie collaboration deal - MSN
Xilio Therapeutics reports $35.8 million in proceeds from Series B warrant exercises By Investing.com - Investing.com South Africa
Xilio Therapeutics reports $35.8 million in proceeds from Series B warrant exercises - Investing.com Nigeria
3.69%
0.68%
자본화:
|
볼륨(24시간):